Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Västerås
Clinical trial register · Sweden

Clinical Trials in Västerås, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Uppsala University5 Karolinska Institutet4 AstraZeneca3 Eli Lilly and Company3 Novartis Pharmaceuticals2
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Västerås

33 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
Emeli Månsson
Phase 4
25
Västerås
2026-01-14
Recruiting
Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy
NCT07003906Surgical Incision, Wound Dehiscence, Surgical Site Infection, Incisional Hernia
Uppsala University
Not applicable
720
Eskilstuna, Linköping, Mora, Norrköping, Uppsala, Västerås
2025-12-16
Recruiting
AstraZeneca
Phase 2
230
Helsingborg, Lund, Malmö, Västerås
2025-12-10
By invitation
Linkoeping University
Not applicable
120
Gothenburg, Helsingborg, Kalmar, Linköping, Lund, Motala, Norrköping, Västerås
2025-11-20
Not yet open
Uppsala University
Not applicable
60
Västerås
2025-09-01
Not yet open
Uppsala University
Observational
35,000
Västerås
2025-08-01
Recruiting
Karolinska Institutet
Not applicable
1,000
Gävle, Halmstad, Linköping, Malmö, Umeå, Västerås
2025-03-03
Recruiting
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
NCT06719206Breast Cancer, Colorectal Cancer (CRC), Prostate Cancer, Neoadjuvant Therapy
Mälardalen University
Not applicable
210
Uppsala, Västerås
2025-03-01
Recruiting
Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy
NCT06777420Breast Cancer Early Stage Breast Cancer (Stage 1-3), Neoadjuvant Therapy, Shared Decision Making
Region Örebro County
Not applicable
218
Uppsala, Västerås, Örebro
2025-03-01
Active, closed
Pfizer
Phase 3
1,035
Gävle, Stockholm, Uppsala, Västerås, Jönköping
2025-01-06
Not yet open
Impact of Behavioral Activation on Depression and Quality of Life in Patients with Colon Cancer
NCT06745700Depression - Major Depressive Disorder, Anxiety, Colon Cancer
Region Västmanland
Not applicable
400
Västerås
2025-01
Active, closed
Clinical Investigation on Lips Treated With HA-filler
NCT07188818Aesthetic Correction of the Lips
Bohus Biotech AB
Not applicable
100
Gothenburg, Karlstad, Malmö, Stockholm, Västerås
2024-12-09
By invitation
Region Västmanland
Not applicable
750
Falun, Västerås
2024-07-01
Recruiting
AstraZeneca
Phase 3
3,850
Alingsås, Gothenburg, Jönköping, Karlstad, Mölndal, Stockholm, Uppsala, Västerås
2024-04-12
Recruiting
Eli Lilly and Company
Phase 3
1,264
Eskilstuna, Västerås
2023-12-21
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Eskilstuna, Gävle, Jönköping, Örebro, Stockholm, Sundsvall, Umeå, Västerås
2023-10-24
Recruiting
Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
NCT05224401Urinary Tract Infections, Bacteremia, Antibiotic Resistant Infection
DrugTrimethoprim-sulfamethoxazole
Lund University
Phase 3
330
Helsingborg, Kristianstad, Lund, Malmö, Västerås
2023-05-29
Recruiting
Neogap Therapeutics AB
Phase 1/2
16
Stockholm, Västerås
2023-03-15
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Gothenburg, Linköping, Lund, Solna, Stockholm, Uppsala, Västerås
2023-03-09
Recruiting
AstraZeneca
Phase 3
3,527
Helsingborg, Huddinge, Lund, Malmö, Solna, Stockholm, Umeå, Västerås
2022-12-13
Recruiting
Karolinska Institutet
Not applicable
712
Stockholm, Gothenburg, Lidköping, Sundsvall, Umeå, Västerås
2022-11-09
Active, closed
Mälardalen University
Not applicable
90
Västerås
2022-10-04
Recruiting
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
NCT05531240Transurethral Resection of Prostate Syndrome, Prostate Hyperplasia, Embolization, Therapeutic
Uppsala University
Not applicable
104
Helsingborg, Eskilstuna, Enköping, Västerås
2022-10-01
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Stockholm, Gothenburg, Falun, Lund, Malmö, Västerås
2021-11-23
Active, closed
Region Örebro County
Not applicable
229
Gävle, Örebro, Västerås
2021-10-01
Active, closed
Ole Frobert, MD, PhD
Not applicable
900
Falun, Gothenburg, Karlstad, Lund, Örebro, Västerås
2021-09-30
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Jönköping, Stockholm, Sundsvall, Uppsala, Västerås
2021-08-27
Recruiting
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
NCT04722692DCIS, Breast Cancer, Breast Neoplasms, Sentinel Lymph Node
Uppsala University
Phase 3
500
Falun, Vaxjo, Lund, Västerås, Gothenburg, Uppsala, Linköping
2020-03-01
Active, closed
AbbVie
Phase 3
964
Malmö, Falun, Solna, Uppsala, Västerås, Örebro
2019-03-25
Recruiting
Karolinska Institutet
Phase 2/3
208
Södertälje, Stockholm, Västerås
2018-03-01
Active, closed
Eli Lilly and Company
Phase 3
5,637
Malmö, Umeå, Sundsvall, Västerås, Vaxjo
2017-07-12
Active, closed
Eli Lilly and Company
Phase 3
493
Gävle, Örebro, Västerås
2014-11-06
Active, closed
Trial on Three Treatments for Scoliosis
NCT01761305Idiopathic Scoliosis
Karolinska Institutet
Not applicable
135
Eskilstuna, Jönköping, Linköping, Stockholm, Sundsvall, Umeå, Västerås
2013-01
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/v-ster-s

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies with a site in Västerås.

How many clinical trials are recruiting in Västerås?

16 of the 33 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 12 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Västerås), 33 studies
PhaseStudiesRecruitingShare
Not applicable15645.5%
Phase 312536.4%
Observational216.1%
Phase 1/2113%
Phase 2113%
Phase 2/3113%
Phase 4113%

Most active sponsors

Lead sponsors with the most studies (Västerås)
Lead sponsorStudiesRecruiting
Uppsala University53
Karolinska Institutet43
AstraZeneca33
Eli Lilly and Company31
Mälardalen University21
Novartis Pharmaceuticals20
Region Västmanland20
Region Örebro County21
AbbVie10
Bohus Biotech AB10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.